Predictive value of baseline metabolic tumor volume in early-stage favorable Hodgkin Lymphoma - Data from the prospective, multicenter phase III HD16 trial.
van Heek L, Stuka C, Kaul H, Müller H, Mettler J, Hitz F, Baues C, Fuchs M, Borchmann P, Engert A, Dietlein M, Voltin C, Kobe C. Predictive value of baseline metabolic tumor volume in early-stage favorable Hodgkin Lymphoma - Data from the prospective, multicenter phase III HD16 trial. BMC cancer 2022; 22:672.
18.06.2022
Predictive value of baseline metabolic tumor volume in early-stage favorable Hodgkin Lymphoma - Data from the prospective, multicenter phase III HD16 trial.
18.06.2022
BMC cancer 2022; 22:672
van Heek Lutz, Stuka Colin, Kaul Helen, Müller Horst, Mettler Jasmin, Hitz Felicitas, Baues Christian, Fuchs Michael, Borchmann Peter, Engert Andreas, Dietlein Markus, Voltin Conrad-Amadeus, Kobe Carsten
Weiter
